fda on bpc 157 classification Survey: Half of Peptide-Users Aren't Aware of Approval Status BPC-157 is shifting off FDA – FDA Advisers Vote to Ease

Response: We thank the commenters for their recommendations and will consider them as we evaluate any potential future measures on this subject

Acta Pharmacol Sin 22:225230 Sikiric P, Jelovac N, Jelovac-Gjeldum A et al (2002) Pentadecapeptide BPC 157 attenuates chronic amphetamine-induced behavior disturbances

Some of the most common peptides for weight loss belong to a class of drugs called glucagon-like peptide 1 (GLP-1) receptor agonists

Neither peptide appears on the Misuse of Drugs Act 1971 Schedules, and neither is classified as a medicine by the MHRA when supplied for legitimate laboratory research purposes